Literature DB >> 25712553

Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor.

Giovanni Cimmino1, Plinio Cirillo, Massimo Ragni, Stefano Conte, Giuseppe Uccello, Paolo Golino.   

Abstract

Tissue factor pathway inhibitor (TFPI) is a serine-protease inhibitor, which modulates coagulation tissue factor-dependent (TF). It binds directly and inhibits the TF-FVII/FVIIa complex as well as FXa. Time to reperfusion of acute ischemic myocardium is essential for tissue salvage. However, reperfusion also results in a unique form of myocardial damage, such as contractile dysfunction, decreased coronary flow and altered vascular reactivity. Oxidants and reactive oxygen species (ROS) formation is increased in the post-ischemic heart and is responsible of post-ischemic injury. It has been reported that ROS promote a procoagulant state via TF expression while no data are available on the effect on TFPI. Endothelial cells were incubated with two different ROS generating systems, xanthine (X)/xanthine oxidase (XO) for 5 min, or H2O2 (500 μM) for 24 h. TFPI activity was measured in supernatants by chromogenic assay and TFPI-mRNA analyzed by RT-PCR 2 h after ROS exposure. Unstimulated cells and cells exposed to either X or XO served as controls. Western blot and ligand dot blot was performed to evaluate ROS effect on TFPI structure and binding to FXa. ROS generated by X/XO as well as H2O2 system resulted in decreased TFPI activity compared to unstimulated cells while X or XO alone had no effect. No differences in TFPI mRNA levels versus controls was observed. A significant degradation of TFPI was induced by ROS exposure, resulting in a decreased ability to bind FXa. ROS induce a procoagulant state in endothelial cells by altering TFPI structure, resulting in inhibition of TFPI binding to Factor Xa and loss of activity. This phenomenon might have important consequences during reperfusion of post-ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25712553     DOI: 10.1007/s11239-015-1199-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  34 in total

1.  Oxygen radicals can induce preconditioning in rabbit hearts.

Authors:  I Tritto; D D'Andrea; N Eramo; A Scognamiglio; C De Simone; A Violante; A Esposito; M Chiariello; G Ambrosio
Journal:  Circ Res       Date:  1997-05       Impact factor: 17.367

2.  Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.

Authors:  P E Morange; S Blankenberg; M C Alessi; C Bickel; H J Rupprecht; R Schnabel; E Lubos; T Münzel; D Peetz; V Nicaud; I Juhan-Vague; L Tiret
Journal:  J Thromb Haemost       Date:  2007-01-04       Impact factor: 5.824

3.  Endothelial G protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species.

Authors:  Michele Ciccarelli; Daniela Sorriento; Antonietta Franco; Anna Fusco; Carmine Del Giudice; Roberto Annunziata; Ersilia Cipolletta; Maria Gaia Monti; Gerald W Dorn; Bruno Trimarco; Guido Iaccarino
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-15       Impact factor: 8.311

4.  Myocardial reperfusion injury: experimental evidence and clinical relevance.

Authors:  D R Holdright; P Taggart; P Sutton; H Swanton
Journal:  Eur Heart J       Date:  1996-11       Impact factor: 29.983

5.  Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation.

Authors:  F Khechai; V Ollivier; F Bridey; M Amar; J Hakim; D de Prost
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

6.  Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients.

Authors:  T Abumiya; T Yamaguchi; T Terasaki; T Kokawa; K Kario; H Kato
Journal:  Thromb Haemost       Date:  1995-10       Impact factor: 5.249

7.  Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation.

Authors:  P Lesnik; C Dentan; A Vonica; M Moreau; M J Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

Review 8.  Tissue factor pathway inhibitor: structure-function.

Authors:  George J Broze; Thomas J Girard
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

9.  TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.

Authors:  Benedicte Stavik; Mari Tinholt; Marit Sletten; Grethe Skretting; Per Morten Sandset; Nina Iversen
Journal:  J Hematol Oncol       Date:  2013-01-15       Impact factor: 17.388

10.  Glutathione protects brain endothelial cells from hydrogen peroxide-induced oxidative stress by increasing nrf2 expression.

Authors:  Juhyun Song; So Mang Kang; Won Taek Lee; Kyung Ah Park; Kyoung Min Lee; Jong Eun Lee
Journal:  Exp Neurobiol       Date:  2014-03-27       Impact factor: 3.261

View more
  9 in total

1.  Targeting SOD1 induces synthetic lethal killing in BLM- and CHEK2-deficient colorectal cancer cells.

Authors:  Babu V Sajesh; Kirk J McManus
Journal:  Oncotarget       Date:  2015-09-29

2.  Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes.

Authors:  Giovanni Cimmino; Loreta Pia Ciuffreda; Giovanni Ciccarelli; Paolo Calabrò; Fiorella Angelica Valeria Ferraiolo; Alessia Rivellino; Raffaele De Palma; Paolo Golino; Francesco Rossi; Plinio Cirillo; Liberato Berrino
Journal:  Front Cardiovasc Med       Date:  2017-02-07

3.  Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice.

Authors:  Maimaiti Yisireyili; Motoharu Hayashi; Hongxian Wu; Yasuhiro Uchida; Koji Yamamoto; Ryosuke Kikuchi; Mohammad Shoaib Hamrah; Takayuki Nakayama; Xian Wu Cheng; Tadashi Matsushita; Shigeo Nakamura; Toshimitsu Niwa; Toyoaki Murohara; Kyosuke Takeshita
Journal:  Sci Rep       Date:  2017-04-28       Impact factor: 4.379

4.  Ref-1 protects against FeCl3-induced thrombosis and tissue factor expression via the GSK3β-NF-κB pathway.

Authors:  Ikjun Lee; Harsha Nagar; Seonhee Kim; Su-Jeong Choi; Shuyu Piao; Moonsang Ahn; Byeong Hwa Jeon; Sang-Ha Oh; Shin Kwang Kang; Cuk-Seong Kim
Journal:  Korean J Physiol Pharmacol       Date:  2021-01-01       Impact factor: 2.016

Review 5.  The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.

Authors:  M Ekholm; T Kahan
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

6.  A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Authors:  E Khan; N L Ambrose; J Ahnström; A P Kiprianos; M R Stanford; D Eleftheriou; P A Brogan; J C Mason; M Johns; M A Laffan; D O Haskard
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

Review 7.  Oxidative Stress Triggers Defective Autophagy in Endothelial Cells: Role in Atherothrombosis Development.

Authors:  Cristina Carresi; Rocco Mollace; Roberta Macrì; Miriam Scicchitano; Francesca Bosco; Federica Scarano; Anna Rita Coppoletta; Lorenza Guarnieri; Stefano Ruga; Maria Caterina Zito; Saverio Nucera; Micaela Gliozzi; Vincenzo Musolino; Jessica Maiuolo; Ernesto Palma; Vincenzo Mollace
Journal:  Antioxidants (Basel)       Date:  2021-03-05

Review 8.  Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Authors:  Maria Elisa Lopes-Pires; Jéssica Oliveira Frade-Guanaes; Gregory J Quinlan
Journal:  Antioxidants (Basel)       Date:  2021-12-30

Review 9.  Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies.

Authors:  Aušra Mongirdienė; Laurynas Skrodenis; Leila Varoneckaitė; Gerda Mierkytė; Justinas Gerulis
Journal:  Biomedicines       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.